title: Possible role of diadenosine polyphosphates in glucose-stimulated insulin release: effects of NaF upon metabolic and functional variables in rat isolated islets.
abstract: Diadenosine polyphosphates, such as diadenosine triphosphate (A2P3) and diadenosine tetraphosphate (A2P4), were recently proposed to participate in the stimulus-secretion coupling for nutrient-stimulated insulin release. Since NaF, an inhibitor of inorganic pyrophosphatase, was reported to lower A2P3 and A2P4 content in glucose-stimulated pancreatic islets, its effects upon metabolic, cationic, biosynthetic and secretory variables in rat pancreatic islets were investigated in the present study. Up to a concentration close to 0.1 mM, NaF failed to affect most of these variables, except for a decrease in 45Ca net uptake. Much higher concentrations of NaF (e.g. 5.0 mM) were required to cause inhibition of the metabolic, ionic, biosynthetic and secretory responses of the islets to nutrient secretagogues. Yet, even at this high concentration, NaF failed to lower the islet content in tritiated A2P3 and A2P4 in islets prelabelled with [2,8-3H]adenosine and failed to prevent the glucose-induced increase in such a content. It is concluded, therefore, that NaF may not represent a suitable tool to assess the participation of diadenosine polyphosphates in the process of nutrient-induced insulin secretion.
authors.affiliation: Laboratory of Experimental Medicine, Brussels Free University, B-1070 Brussels, Belgium.
authors.forename: P
authors.initials: P
authors.lastname: Courtois
authors.forename: K
authors.initials: K
authors.lastname: Louchami
authors.forename: A
authors.initials: A
authors.lastname: Laghmich
authors.forename: S
authors.initials: S
authors.lastname: Picton
authors.forename: H
authors.initials: H
authors.lastname: Jijakli
authors.forename: A
authors.initials: A
authors.lastname: Sener
authors.forename: W J
authors.initials: WJ
authors.lastname: Malaisse
mesh_terms: D000818:Animals; D002118:Calcium / Q000493:pharmacokinetics; D002132:Calcium Radioisotopes / Q000493:pharmacokinetics; D015226:Dinucleoside Phosphates / Q000378:metabolism*; D005260:Female; D005947:Glucose / Q000378:metabolism; D066298:In Vitro Techniques; D043564:Inorganic Pyrophosphatase; D007328:Insulin / Q000378:metabolism*; D007515:Islets of Langerhans / Q000187:drug effects* / Q000378:metabolism*; D010455:Peptides / Q000378:metabolism; D010477:Perfusion; D011755:Pyrophosphatases / Q000037:antagonists & inhibitors; D051381:Rats; D017208:Rats, Wistar; D012969:Sodium Fluoride / Q000494:pharmacology*
chemical_list: D002132:Calcium Radioisotopes; D015226:Dinucleoside Phosphates; D007328:Insulin; D010455:Peptides; C020733:diadenosine tetraphosphate; C011440:diadenosine triphosphate; D012969:Sodium Fluoride; D011755:Pyrophosphatases; D043564:Inorganic Pyrophosphatase; D005947:Glucose; D002118:Calcium